Form 8-K - Current report:
SEC Accession No. 0001829126-25-003427
Filing Date
2025-05-06
Accepted
2025-05-06 12:39:21
Documents
16
Period of Report
2025-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nexalintec_8k.htm   iXBRL 8-K 36290
2 EXHIBIT 10.1 nexalintec_ex10-1.htm EX-10.1 203581
3 EXHIBIT 99.1 nexalintec_ex99-1.htm EX-99.1 9979
  Complete submission text file 0001829126-25-003427.txt   522509

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nxl-20250504.xsd EX-101.SCH 3750
5 XBRL DEFINITION FILE nxl-20250504_def.xml EX-101.DEF 26614
6 XBRL LABEL FILE nxl-20250504_lab.xml EX-101.LAB 36724
7 XBRL PRESENTATION FILE nxl-20250504_pre.xml EX-101.PRE 25238
18 EXTRACTED XBRL INSTANCE DOCUMENT nexalintec_8k_htm.xml XML 5832
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41507 | Film No.: 25916316
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)